7 alpha-hydroxy-4-cholesten-3-one has been researched along with Diabetes Mellitus, Adult-Onset in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Acevedo, L; Dorenbaum, A; Gedulin, B; Keller, BT; Kennedy, CA; Levin, N; Palmer, M; Tiessen, RG; van Vliet, AA | 1 |
| Drexel, H; Othman, A; Rein, P; Rentsch, KM; Saely, CH; Steiner, C; von Eckardstein, A | 1 |
1 trial(s) available for 7 alpha-hydroxy-4-cholesten-3-one and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Safety, tolerability and pharmacodynamics of apical sodium-dependent bile acid transporter inhibition with volixibat in healthy adults and patients with type 2 diabetes mellitus: a randomised placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Benzothiepins; Bile Acids and Salts; Blood Glucose; Cholestenones; Diabetes Mellitus, Type 2; Double-Blind Method; Feces; Female; Glycosides; Homeostasis; Humans; Lipid Metabolism; Male; Membrane Glycoproteins; Middle Aged; Non-alcoholic Fatty Liver Disease; Organic Anion Transporters, Sodium-Dependent; Symporters; Young Adult | 2018 |
1 other study(ies) available for 7 alpha-hydroxy-4-cholesten-3-one and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Bile acid metabolites in serum: intraindividual variation and associations with coronary heart disease, metabolic syndrome and diabetes mellitus.
Topics: Adult; Aged; Bile Acids and Salts; Case-Control Studies; Cholestenones; Coronary Artery Disease; Diabetes Mellitus, Type 2; Eating; Female; Humans; Logistic Models; Male; Metabolic Syndrome; Middle Aged; Principal Component Analysis; Time Factors | 2011 |